This is out Library. Please click on the article title to view the details.
submitted by: admin on 11/23/2019
According to researchers at the University of California Medical Center, and published in the March issue of Internal Medicine, screening for breast cancer every two years is preferrable to yearly screens when doing mammograms. This was based on a study of 900,000 women. It appears that this applies to women from the age of 50-94. Mammograms picked...
submitted by: admin on 06/25/2016
The important statistics about breast cancer are reviewed. Risk factors and three main cellular types are described. Mainstream and alternative treatments are reviewed. Integrative strategies make the most sense.
submitted by: admin on 09/19/2013
The FDA published information in Journal Watch in June of 2011 that is packed with presumptive and incorrect information about breast thermography and they have to know it! Breast thermography was approved in 1982 as an adjunct to mammography to evaluate for breast cancer. In 2004 the FDA rejected breast thermography as a stand alone test for breast...
submitted by: admin on 02/17/2015
No one wants to get cancer but if we do, we want to find it early when it might be more curable. Keep in mind that cancer screening is not the same as prevention. There are a wide range of cancer screening tests that are available today that are regularly prescribed by the medical profession that have been assumed with a very limited scientific basis to be beneficial.
However,...
submitted by: admin on 09/03/2014
This is a PowerPoint presentation on why doctors should expand the boundaries of breast cancer screening by including breast thermography. The FDA approved this test in 1982 as an adjunct to mammography. Because it adds important information about the physiology of how breast cancers behave rather than just their anatomy, so it adds an additional valuable way...
submitted by: admin on 07/29/2019
According to a paper presented at the December 2013 annual meeting of the Radiological Society of North America, breast tomosynthesis (a limited CT scan of the breast) is a better test than the digital mammogram because it is a more sensitive test that finds breast cancers (22% more), is it associated with a lower recall rate because of false positive tests (15%fewer),...
submitted by: admin on 10/10/2013
In a recent report on mammograms published in the New York Times, they say that most women should start breast cancer screening at age 50 not 40 according to new guidelines. They also recommend mammograms be done every two years rather than every year. The new recommendations are aimed at reducing harm from over treatment. The report also suggests...
submitted by: admin on 06/18/2016
One third of cancers detected by mammography may not be life-threatening according to the November of 2012 issue of the New England Journal of Medicine. Over the past 3 decades, an estimated 1.3 million women have been over-diagnosed of breast cancer that has led to treatment for a cancer for which they did not need treatment.
Many of these cancers...
submitted by: admin on 11/02/2024
A novel new test is described that has not yet come into clinical practice that takes up a radioactive dye that puts out gamma rays. It is accurate but obviously has dangers related to radiation exposure. This is a potential way of screening women with dense breasts (fibrocystic breasts).
Mammograms are not either an accurate or sensitive test in women with...
submitted by: admin on 10/14/2013
The Centers for Medicare and Medicaid Services (CMS) reports that 5 million Americans took advantage of one or more of the recommended preventive benefits available through the Affordable Care Act. Among the benefits is the new Annual Wellness Visit benefit. The idea is to either detect early or prevent chronic diseases with tests such as mammograms, bone...
submitted by: admin on 11/02/2024
There is considerable confusion about the role of mammograms in breast cancer detection in premenopausal women. The US is the only country in the world making the recommendation that they be done on women in this age group. The people standing to profit from doing mammograms in this age group are the mammogram industry, Big pharma in the sale of chemotherapy,...
submitted by: admin on 09/01/2014
A study out of the University of North Carolina Medical Center in August of 2014 studied more than 27,000 patients over the age of 65 and questioned the widsom of doing routine cancer screening tests, especially if they had a limited life expectancy. They looked at screening tests for prostate, breast, colon, and cervix in a study from 2000 through 2010 and compared...
submitted by: admin on 06/18/2016
The May of 2012 issue of the New England Journal of Medicine reports that sigmoidoscopy rather than colonoscopy could be used to screen for colon cancer. A clinical trial of 150,000 people was done where half had sigmoidoscopy and the other have nothing. They were followed over 12 years and over that interval there were 89 fewer cancer deaths and 275 more colon...
submitted by: admin on 02/24/2014
The conclusion of a 25 year prospective study published in the British Medical Journal in February of 2014 was that screening mammograms not only do not save lives but also lead to a 22% over-diagnosis that leads to unnecessary testing and treatment in women between the ages of 50 and 69.
After all these years of policy set by governments, research...